![Konstantina Katcheves](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Konstantina Katcheves
Direttore/Membro del Consiglio presso
MIRATI THERAPEUTICS
Profilo
Konstantina Katcheves is currently Director at Mirati Therapeutics, Inc., Director at Rayzebio, Inc., Director at Karuna Therapeutics, Inc., and SVP, Chief Business & Strategy Officer at ACADIA Pharmaceuticals, Inc. Formerly, Ms. Katcheves was Senior Vice President-Global Business Development at Teva Pharmaceutical Industries Ltd. Education includes graduate studies at The Johns Hopkins University, undergraduate studies at the University of California, and graduate studies at the University of Oklahoma College of Law.
Posizioni attive di Konstantina Katcheves
| Società | Posizione | Inizio |
|---|---|---|
| MIRATI THERAPEUTICS | Direttore/Membro del Consiglio | 23/01/2024 |
| RAYZEBIO, INC. | Direttore/Membro del Consiglio | 26/02/2024 |
| KARA THER | Direttore/Membro del Consiglio | 18/03/2024 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 25/08/2025 |
Precedenti posizioni note di Konstantina Katcheves
| Società | Posizione | Fine |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - |
Formazione di Konstantina Katcheves
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
53
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oklahoma College of Law
 University of Oklahoma College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
